PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31150632-0	2019	Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing.	schizandrin B	59-72	C-C motif chemokine ligand 4	Rattus norvegicus	84-88	
9350055-5	1997	Both insulin and schisandrin B (Sch B) pretreatments protected against the CCl4 hepatotoxicity in diabetic rats.	schizandrin B	17-30	C-C motif chemokine ligand 4	Rattus norvegicus	75-79	
31150632-3	2019	This study aimed to investigate the therapeutic effects and molecular mechanisms of Sch B against CCl4-induced liver fibrosis in rats.	schizandrin B	84-89	C-C motif chemokine ligand 4	Rattus norvegicus	98-102	
31150632-5	2019	The results demonstrated that Sch B effectively alleviated CCl4-induced liver damage and fibrosis in rats, as evidenced by improved liver function and decreased extracellular matrix deposition.	schizandrin B	30-35	C-C motif chemokine ligand 4	Rattus norvegicus	59-63	
31150632-10	2019	In conclusion, our study demonstrated Sch B alleviated CCl4-induced liver fibrosis by multiple modulatory mechanisms, which provide new clues for further pharmacological study of Sch B.	schizandrin B	38-43	C-C motif chemokine ligand 4	Rattus norvegicus	55-59	
28794616-4	2017	The in vivo therapeutic effect of Sch B on liver fibrosis induced by CCl4 was examined in rats.	schizandrin B	34-39	C-C motif chemokine ligand 4	Rattus norvegicus	69-73	
28794616-0	2017	Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-beta/Smad signaling pathways.	schizandrin B	0-13	C-C motif chemokine ligand 4	Rattus norvegicus	25-29	
28794616-3	2017	This study aimed to investigate the protective effect and related molecular mechanism of Sch B against carbon tetrachloride (CCl4)-induced liver fibrosis in rats.	schizandrin B	89-94	C-C motif chemokine ligand 4	Rattus norvegicus	125-129